Merck Product Theater

Join us Thursday May 20, 2021 at 6:30pm -7:15pm EDT

A Treatment Approach for Certain Patients With High-Risk
Non-muscle Invasive Bladder Cancer (NMIBC)

Learning Objectives:

• Review the features of NMIBC
• Evaluate the clinical data on a treatment option for certain patients with high-risk NMIBC
• Understand the safety data associated with this treatment option for certain patients with high-risk NMIBC

Speaker:  Michael Fabrizio, MD

Michael Fabrizio, MD is a Urologist, Professor of Urology at Eastern Virginia Medical School, and immediate past CEO at Urology of Virginia, in Virginia Beach, VA. He has directed the Endourology Fellowship for the last 16 years.  Dr. Fabrizio attended Medical College of Virginia and completed his residency at Thomas Jefferson University Hospital in Philadelphia followed by postgraduate training in Urology at The Johns Hopkins University, Brady Urological Institute. He is board certified in Urology and a Fellow of the American College of Surgeons. Dr. Fabrizio is also a Past-President of The MidAtlantic Section of American Urological Association and a member of the American Urological Association. He has published extensively and operated and lectured worldwide.

Register Here

This event will be preceded by LUGPA's Innovation Theater on "High-Risk NMIBC" moderated by Lawrence Karsh, MD and Neal Shore, MD.